Scientists have advanced the field of cancer treatment by leveraging the body’s immune system to recognize and target tumors.
KUALA LUMPUR, Malaysia, June 02, 2026 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) ("VCI Global" or the "Company"), through its wholly owned technology and infrastructure subsidiary V Gallant ...
Acute kidney injury (AKI) is a common clinical syndrome characterized by substantial etiologic heterogeneity, whose pathophysiology encompasses inflammatory amplification, microcirculatory dysfunction ...
JUPITER, FL, May 20, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage biopharmaceutical company focused on central nervous system ...
Patients with ALS, or Lou Gehrig's disease, live an average of only three years after symptoms begin, though some can survive closer to 10 years. What drives these differences in survival has remained ...
Converge ICT Solutions Inc. is scaling up its workforce to support network expansion and maintenance following significant investments in digital infrastructure. Following the launch of its National ...
In 2026, L.A. isn’t just a market where influencers film sunrise content on Venice Beach or collaborate in Soho House stairwells; it’s the infrastructure hub where platforms, tools and businesses that ...
The Energy and Resources Institute (TERI) convened a Pre-Event Press Conference for the World Sustainable Development Summit (WSDS) 2026 (Silver Jubilee Edition) on 3 February 2026 at India Habitat ...
Alzheimer’s may destroy memory by flipping a single molecular switch that tells neurons to prune their own connections. Researchers found that both amyloid beta and inflammation converge on the same ...
ABU DHABI, 5th November, 2025 (WAM) -- M42, a global health leader powered by technology, AI and genomics, has announced a strategic partnership with 10X Health (USA) and REVIV Global (UK) to launch ...
The Complement System (CS) comprises three catalytic pathways that can be activated by specific immune triggers. However, within the tumor microenvironment (TME), CS intracellular components, recently ...